Vitamin K antagonists (dose-adjusted)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Vitamin K antagonists (dose-adjusted), covering 2019-01-10 to 2019-01-10. Get the full timeline:
Most recent: Clinical Trial Update: Rivaroxaban Once Daily Versus Dose-adjusted Vitamin K Antagonist on the Biomarkers in Acute Decompensated Heart Failure and Atrial Fibrillation (ROAD HF-AF) [Phase 4]